A matched-cohort study of selected clinical and utilization outcomes for an asthma care support program

Disease Management

Volumn 8, Issue 3, 2005, Pages 144-154

  Johnson, Alan ^a,c   Berg, Gregory ^a   Fleegler, Edward ^a   Sauerbrun, Marilyn ^b  

^a McKesson   (United States)

^b Anthem Blue Cross and Blue Shield   (United States)

^c McKesson Health Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE MODIFIERS; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK POPULATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; SELF CARE;

EID: 21744439117     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2005.8.144     Document Type: Article

References (41)

1. American Lung Association. Trends asthma morbidity mortality. April 2004.
2. Centers for Disease Control and Prevention. Survellance for asthma - Unites States, 1980-1989: MMWR 2002;51:1-13.
3. American Lung Association. Epidemiology and Statistics Unit. Best practices and program services. Trends Asthma Morbidity Mortality 2002;1-25.
4. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood) 2001;20:233-241.
5. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2002 chart book on cardiovascular, lung, and blood diseases. Washington, DC: NHLBI, 2003.
6. Pappas G, Hadden WC, Kozak LJ, Fisher GF. Potentially avoidable hospitalizations: inequalities in rates between U.S. sociatioeconomic groups. Am J Public Health 1997;97:811-816.
7. Friday GA Jr, Khine H, Lin MS, Caliguiri LA. Profile of children requiring emergency treatment for asthma. Am Allergy Asthma Immunol 1997;78:221-224.
8. Hartert TV, Windom HH, Beebles RS Jr, Friedhoff LR, Togias A. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996;100:386-394.
9. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: Prevalence, health care utilization, and mortality. Pediatrics 2002;110:315-322.
10. Institute for the Future. Weaving disease management into the fabric of patient care. Available 〈www.iftf.org/html/membershipprograms/ healthcarehorizons/index.htm〉, 2000.
11. Disease Management Purchasing Consortium & Advisory Council. What unions need to know about disease management. Available 〈www.idsmgmt.com/ frame15.asp〉, 2004.
12. Gillespie JL. The value of disease management - Part 3: Balancing cost and quality in the treatment of asthma. Dis Manage 2002;5:225-232.
13. Maljanian R, Wolf S, Goether J, Hernandez P, Horowitz S. An inner-city asthma disease management initiative: results of an outcomes evaluation. Dis Manage Health Outcomes 1999;5:285-293.
14. Burton WN, Schultz AB, Connerty CM, Chen C-Y, Edington DW. Asthma disease management: a worksite-based asthma education program. Dis Manage 2001;4:3-13.
15. Fireman P, Friday GA, Gira C, Vierthaler WA, Michels L. Teaching self-management skills to asthmatic children and their parents in an ambulatory care setting. Pediatrics 1981;68:341-348.
16. Grupp-Phelan J, Lozano P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidities. J Asthma 2001;38:363-373.
17. Institute for the Future. Weaving disease management into the fabric of patient care. Available: 〈www.iftf.org/html/membershipprograms/ healthcarehorizons/index.htm〉, 2000.
18. Gillespie JL. Disease management: balancing cost and quality. Washington, DC: National Pharmaceutical Council, 1999.
19. NCQA News. NCQA Announces intention to certify disease management programs. Available: 〈www.ncqa.org/Pages/communications/news/ disease_management.htm〉, 2001.
20. NAEPP. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. NIH publication no. 97-4051. Washington, DC: NIH. 1997.
21. National Asthma Education and Prevention Program Expert Panel Report. Guidelines for the diagnosis and management of asthma update on selected topics - 2002. J Allergy Clin Immunol 2002;110:S141-S219.
22. HEDIS© 2003. Volume 2. Technical specifications update. Available: 〈www.ncqa.org/Program/HEDIS/hedis2003NDClists.htm〉, 2003.
23. Center for Drug Evaluation and Research. Major drug class. Available: 〈www.fda.gov/cder/ndc/index.htm〉, 2002.
24. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies of causal effect. Biometrika 1983;76:44-51.
25. Rosenbaum PR, Dubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984;79:516-524.
26. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985;39:33-38.
27. Rubin DB. Matching using estimated propensity scores: relation theory to practice. Biometrics 1996;52:249-264.
28. Dehejia RH, Wahba S. Propensity score-matching methods for nonexperimental causal studies. Rev Econ Stat 2002;84:151-161.
29. Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Services Outcomes Res Methodol 2001;2:169-188.
30. Frigoletto FD Jr, Lieberman E, Lang JM, et al. A clinical trial of active management of labor. N Engl J Med 1995;333:745-750.
31. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis. JAMA 2001;286:1187-1194.
32. Peterson JG, Topol EJ, Roe MT, et al. Prognostic importance of concomitant hepartin with eptifibatide in acute coronary syndromes. Am J Cardiol 2001;87:532-536.
33. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996;276:889-897.
34. nd ed. Philadelphia: Lippincott Williams & Williams, 1988.
35. Ensom MH. Gender-based differences and menstrual cycle-related changes in specific diseases: implications for pharmacotherapy. Pharmacotherapy 2000;20:523-539.
36. Singh AK, Cydulka RK, Stahmer SA, Woodruff PG, Camargo J. Sex differences among adults presenting to the emergency department with acute asthma. JAMA 1999;159:1237-1243.
37. American Lung Association. State of the air 2002. Asthma in children fact sheet. Available: 〈www.lungsusa.org/asthma/ascpedfac99.html〉, 2002.
38. American Lung Association. Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001;345:1529-1536.
39. Kramarz P, DeStefano F, Garguillo P, et al. Does influenza vaccination exacerbate asthma? Arch Fam Med 2000;9:617-723.
40. Landrum MB, Ayanian J. Causal effect of ambulatory specialty care on mortality following myocardial infarction: a comparison of propensity score and instrumental variable analysis. Health Services Outcomes Res Methodol 2001;2:221-245.
41. Drake C. Effects of misspecification of the propensity score on estimators of treatment effects. Biometrics 1993;49:1231-1236.